Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650



 Company News
Isis Pharmaceuticals, Inc. (ISIS) Earns $7M for Advancing ISIS-SMN Rx In Children With Spinal Muscular Atrophy 1/14/2015 7:16:36 AM
Isis Pharmaceuticals, Inc. (ISIS) Significantly Improves Upon 2014 Financial Guidance 1/8/2015 9:06:18 AM
Interleukin Genetics Inc. (ILGN) Announces Collaboration With Isis Pharmaceuticals, Inc. (ISIS) For Genetic Testing Services 1/7/2015 12:41:59 PM
Led By Ex-Genzyme Corporation (GENZ) Exec, Isis Pharmaceuticals, Inc. (ISIS)'s Newly Formed Cambridge Subsidiary to Hire 20 1/7/2015 6:36:59 AM
Isis Pharmaceuticals, Inc. (ISIS) Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics 1/6/2015 9:25:34 AM
Isis Pharmaceuticals, Inc. (ISIS) Appoints Sarah Boyce As Chief Business Officer 1/6/2015 9:03:36 AM
Isis Pharmaceuticals, Inc. (ISIS) Rockets as Johnson & Johnson (JNJ) Snags Bowel Drug License Option for $835 Million 1/5/2015 6:08:24 AM
Isis Pharmaceuticals, Inc. (ISIS) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/2/2015 9:56:37 AM
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 1/2 Study Of ISIS-DMPK Rx In Patients With Myotonic Dystrophy Type 1 12/16/2014 8:08:48 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Phase 2 Data For ISIS-FXI Rx For The Prevention Of Venous Thrombosis In Patients Undergoing Total Knee Replacement Surgery 12/8/2014 7:57:14 AM